Citius Oncology, Inc. (CTOR)

Citius Oncology Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Cash & Equivalents	7.3	3.92	0	-	-
Cash & Short-Term Investments	7.3	3.92	0	-	-
Cash Growth	6513695.54%	3504282.14%	-	-	-
Inventory	22.64	22.29	8.27	-	-
Prepaid Expenses	3.16	1.33	2.7	7.73	2.69
Total Current Assets	37.15	27.54	10.97	7.73	2.69
Long-Term Deferred Charges	72.83	73.4	73.4	40	40
Total Assets	109.97	100.94	84.37	47.73	42.69
Accounts Payable	10.45	13.23	3.71	1.29	0.09
Accrued Expenses	16.01	13.61	0.59	19.76	5.75
Other Current Liabilities	18.25	22.65	28.4	-	-
Total Current Liabilities	44.71	49.49	32.7	21.05	5.85
Long-Term Debt	3.8	3.8	3.8	-	-
Long-Term Deferred Tax Liabilities	3.05	2.78	1.73	1.15	0.58
Other Long-Term Liabilities	-	-	-0	-	-
Total Liabilities	51.56	56.08	38.23	22.2	6.42
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	127.98	108.9	85.41	43.66	41.69
Retained Earnings	-69.57	-64.04	-39.28	-18.13	-5.43
Shareholders' Equity	58.41	44.87	46.14	25.54	36.27
Total Liabilities & Equity	109.97	100.94	84.37	47.73	42.69
Total Debt	3.8	3.8	3.8	-	-
Net Cash (Debt)	3.5	0.12	-3.8	-	-
Net Cash Per Share	0.05	0.00	-0.06	-	-
Filing Date Shares Outstanding	88.28	84.8	71.55	67.5	67.5
Total Common Shares Outstanding	84.8	83.51	71.55	67.5	67.5
Working Capital	-7.56	-21.95	-21.73	-13.31	-3.16
Book Value Per Share	0.69	0.54	0.64	0.38	0.54
Tangible Book Value	58.41	44.87	46.14	25.54	36.27
Tangible Book Value Per Share	0.69	0.54	0.64	0.38	0.54

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q